BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Omae K, Ogawa T, Nitta K. Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease. Heart Vessels 2009;24:301-7. [PMID: 19626404 DOI: 10.1007/s00380-008-1125-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Moore KH, Clemmer JS. Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling. Am J Physiol Renal Physiol 2021;321:F548-57. [PMID: 34486399 DOI: 10.1152/ajprenal.00233.2021] [Reference Citation Analysis]
2 Hayashi K, Saruta T, Goto Y, Ishii M; JATOS Study Group. Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine. Hypertens Res 2010;33:1211-20. [PMID: 20844543 DOI: 10.1038/hr.2010.162] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
3 Hayashi K. L-/T-type Ca channel blockers for kidney protection: ready for sophisticated use of Ca channel blockers. Hypertens Res 2011;34:910-2. [DOI: 10.1038/hr.2011.74] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial. Hypertens Res 2013;36:947-58. [PMID: 23864054 DOI: 10.1038/hr.2013.63] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
5 Aritomi S, Koganei H, Wagatsuma H, Mitsui A, Ogawa T, Nitta K, Konda T. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet. Heart Vessels 2010;25:549-55. [PMID: 20922532 DOI: 10.1007/s00380-010-0005-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
6 Matejka J, Varvarovsky I, Vojtisek P, Herman A, Rozsival V, Borkova V, Kvasnicka J. Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease. Heart Vessels 2010;25:536-42. [PMID: 20878408 DOI: 10.1007/s00380-010-0004-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
7 Hayabuchi Y, Nakaya Y, Mawatari K, Inoue M, Sakata M, Kagami S. Cell membrane stretch activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells. Heart Vessels 2011;26:91-100. [PMID: 21063882 DOI: 10.1007/s00380-010-0025-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
8 Homma K, Hayashi K, Yamaguchi S, Fujishima S, Hori S, Itoh H. Renal microcirculation and calcium channel subtypes. Curr Hypertens Rev 2013;9:182-6. [PMID: 24479750 DOI: 10.2174/1573402110666140131160617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
9 Davis S, Raju AR, Thomas E, Cherian JJ. Efonidipine-Induced Exanthematic Drug Eruption and Literature Review: . Journal of Cardiovascular Pharmacology 2019;73:394-6. [DOI: 10.1097/fjc.0000000000000676] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]